Senior Investigator Profile

TitleProfessor
First NameMervyn
SurnameSinger
Award StatusEmeritus
Current PostProfessor of Intensive Care Medicine
DepartmentCritical Care/Medicine
Telephone0207 679 6714
Emailm.singer@ucl.ac.uk
InstitutionUniversity College London
NHS TrustUniversity College London Hospitals NHS Foundation Trust
Region NameLondon
Primary Research FieldIntensive Care
Secondary Research FieldIntensive Care
BiographyMervyn Singer is Professor of Intensive Care Medicine at University College London.  Achievements to date include (i) developing a haemodynamic monitoring device (now used in >30 countries) whose use has been shown to reduce post-operative complications and length of hospital stay, (ii) major studies into the pathogenesis and management of sepsis, shock and multi-organ failure, and (iii) lead clinical investigator of the PAC-Man study, the first academic-funded multicentre study in UK critical care. His group has won 15 national and international research awards, and he has gained over £15m in funding, mainly from the NIHR, MRC, the Wellcome Trust and the European Commission. He is currently involved in the academic development of two novel monitoring devices for assessing tissue perfusion (one of which is entering clinical trials), a new drug for treating ischaemia-reperfusion injury and a new drug for treating septic shock, as well as several industry collaborations of novel devices and therapeutics. He has written/edited ten textbooks, including the Oxford Handbook of Critical Care, now in its 3rd Edition. He sits on the Council of the International Sepsis Forum and is a Panel Member of the Wellcome Trust Technology Transfer Committee and the Health Innovation Challenge Fund.
 

 CVName
View CV151_CV.doc
















<< Search SI Directory